These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8326162)

  • 1. The efficacy of a five-drug antiemetic combination during chemotherapy regimens containing cisplatin or cyclophosphamide-doxorubicin.
    Aydiner A; Onat H; Oztürk N; Aykan F; Inanc S; Topuz E; Dincol K
    J Pain Symptom Manage; 1993 Apr; 8(3):126-31. PubMed ID: 8326162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin.
    Cleri LB; Kris MG; Tyson LB; Pisters KM; Clark RA; Gralla RJ
    Cancer; 1995 Sep; 76(5):774-8. PubMed ID: 8625179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
    Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research.
    Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent improvements in antiemetic therapy].
    Roila F; Palladino MA; Ciccarese G; Basurto C
    Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimen.
    Plezia PM; Alberts DS; Kessler JF; Berens PL; Chase JL; Roe DJ
    J Pain Symptom Manage; 1990 Apr; 5(2):101-8. PubMed ID: 2189929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
    J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate termination of intractable vomiting induced by cisplatin combination chemotherapy using an intensive five-drug antiemetic regimen.
    Plezia PM; Alberts DS; Kessler J; Aapro MS; Graham V; Surwit EA
    Cancer Treat Rep; 1984 Dec; 68(12):1493-5. PubMed ID: 6542448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination antiemetics for cisplatin chemotherapy.
    Sridhar KS; Donnelly E
    Cancer; 1988 Apr; 61(8):1508-17. PubMed ID: 3280112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.
    Kimura H; Yamamoto N; Shirai T; Nishida H; Hayashi K; Tanzawa Y; Takeuchi A; Igarashi K; Inatani H; Shimozaki S; Kato T; Aoki Y; Higuchi T; Tsuchiya H
    Cancer Med; 2015 Mar; 4(3):333-41. PubMed ID: 25533447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.
    Fraschini G; Ciociola A; Esparza L; Templeton D; Holmes FA; Walters RS; Hortobagyi GN
    J Clin Oncol; 1991 Jul; 9(7):1268-74. PubMed ID: 1828499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens.
    Kubota K; Saito M; Aogi K; Sekine I; Yoshizawa H; Yanagita Y; Sakai H; Inoue K; Kitagawa C; Ogura T
    Support Care Cancer; 2016 Sep; 24(9):4025-33. PubMed ID: 27129842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betamethasone-dixyrazine combination versus high-dose metoclopramide as antiemetic treatment in doxorubicin and cisplatin chemotherapy.
    Sorbe B; Hallén C; Skåre NG; Underskog I
    Radiother Oncol; 1989 Jun; 15(2):161-7. PubMed ID: 2762589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High efficacy of a single oral dose of ondansetron 8 mg versus a metoclopramide regimen in the prevention of acute emesis induced by fluorouracil, doxorubicin and cyclophosphamide (FAC) chemotherapy for breast cancer.
    Bosnjak SM; Nesković-Konstantinović ZB; Radulović SS; Susnjar S; Mitrovi LB
    J Chemother; 2000 Oct; 12(5):446-53. PubMed ID: 11128567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study.
    Gebbia V; Testa A; Cannata G; Gebbia N
    Anticancer Drugs; 1996 Sep; 7(7):734-7. PubMed ID: 8949983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients.
    Dogliotti L; Antonacci RA; Pazè E; Ortega C; Berruti A; Faggiuolo R
    Drugs; 1992; 43 Suppl 3():6-10. PubMed ID: 1380432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of an antiemetic regimen with a high-dose metoclopramide, dexamethasone and diphenhydramine combination in chemotherapy regimens with cisplatin].
    Abad-Esteve A; Rosell R; Moreno I; Monrás P; Fernández C; Serichol M; Clotet M; Ribas Mundó M
    Med Clin (Barc); 1986 Dec; 87(19):796-8. PubMed ID: 3821231
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer].
    Fujii T; Nakata N; Shiroyama Y; Sawasaki T; Tanimoto H; Shigemasa K; Kioka H; Naito H
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2245-52. PubMed ID: 9422069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.